Dare Bioscience Inc (DARE)

[chmcnfunds]

Hope analysts are correct. I'll take a piece of the target price:

Consensus Ratings for Cerulean Pharma (NASDAQ:CERU)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating: Buy (Score: 3.00)
Consensus Price Target: $14.40 (134.15% upside)

_____________________________________


http://www.analystratings.net/stocks/NASDAQ/CERU/

CERU